Goodwill Impairment Surge 2026: Why War Risk, Rising Discount Rates & Supply Chain Shocks Are Triggering Impairment Tests Across Sectors

The Impairment Wave Is Already Here

In boardrooms and audit committee meetings across the US, UK, and Australia, the same conversation is happening with increasing urgency in 2026.

A business acquired in 2019 or 2021 — at peak multiples, in a low-rate environment, with pre-war supply chain assumptions — now carries goodwill on the balance sheet that was calculated when the cost of capital was 6%, energy was cheap, and geopolitical risk was an abstraction rather than a daily operational reality.

In 2026, the cost of capital for that same business is 9–11%. Energy costs are structurally elevated. Supply chains have been reorganised at significant cost. And the strategic rationale for the acquisition — access to Eastern European markets, a China-dependent manufacturing footprint, a logistics network built around Red Sea shipping routes — may have been materially impaired by events that no acquisition model anticipated.

The mathematical relationship is direct and unforgiving: when the discount rate rises, the present value of future cash flows falls. When the present value of future cash flows falls below the carrying amount of goodwill on the balance sheet, impairment is triggered. No management judgement, no auditor discretion, no accounting flexibility can change this arithmetic.

What has changed in 2026 is the scale and breadth of the businesses approaching — or already crossing — that impairment threshold. The combination of higher WACCs (driven by persistent inflation and central bank policy), war-driven cash flow disruptions, and tariff-driven margin compression has created conditions for the most significant goodwill impairment cycle since the post-GFC write-downs of 2009–2010.

This blog is a practical guide for CFOs, PE fund finance teams, audit committee members, and advisory firms who need to understand what is driving the impairment wave, which sectors are most exposed, what the correct methodology looks like under current standards, and what to do if your business is approaching the impairment threshold.

For the full WACC rebuild methodology that underpins impairment testing in the current environment, read our WACC and DCF rebuild guide for 2026 alongside this blog.

The Mechanics of Goodwill Impairment — Why 2026 Is Different

How Goodwill Impairment Works Under ASC 350, IAS 36, and AASB 136

Goodwill arises when a business is acquired for more than the fair value of its identifiable net assets. Under all three major accounting standards — ASC 350 (US GAAP), IAS 36 (IFRS), and AASB 136 (Australian standards) — goodwill is not amortised but is tested for impairment annually, or more frequently when indicators of impairment exist.

The impairment test works as follows:

Under ASC 350 (US GAAP): The reporting unit’s fair value is compared to its carrying amount including goodwill. If fair value is less than carrying amount, the difference is recognised as an impairment loss — limited to the amount of goodwill allocated to that reporting unit.

Under IAS 36 / AASB 136: The recoverable amount of each cash-generating unit (CGU) — defined as the higher of fair value less costs of disposal and value in use — is compared to the CGU’s carrying amount. If recoverable amount is less than carrying amount, an impairment loss is recognised.

In practice, the value-in-use calculation under IAS 36 / AASB 136 is a discounted cash flow — which means it is directly and immediately affected by WACC changes. A 2-percentage-point increase in the discount rate applied to a CGU with $50M of projected annual cash flows over a 10-year horizon reduces the present value of those cash flows by approximately $8–12M — a reduction that flows directly into the recoverable amount calculation and potentially into an impairment charge.

Our goodwill and intangible impairment testing service is structured around all three standards — with specific methodology documentation for US, UK, and Australian clients.

The Three Forces Creating the 2026 Impairment Wave

Force 1 — Rising Discount Rates: As we documented in detail in our WACC rebuild guide, the risk-free rate has increased by 3.0–4.2 percentage points since 2021 depending on currency, the equity risk premium has moved higher, and country risk premiums for geopolitically exposed markets have increased significantly. The cumulative effect on WACC for a typical mid-market business is a 3–5 percentage point increase — which, in a value-in-use calculation, can eliminate impairment headroom that looked comfortable as recently as 2023.

Force 2 — War-Driven Cash Flow Disruption: Businesses that were acquired based on cash flow projections that included Eastern European revenue, Russian market access, Red Sea shipping efficiency, or Ukraine-dependent supply chains have seen those cash flows materially disrupted. The gap between the acquisition model’s projected cash flows and the actual cash flows now achievable in the post-war environment is precisely the kind of negative variance that triggers impairment indicators under both ASC 350 and IAS 36.

Force 3 — Tariff-Driven Margin Compression: US tariffs on Chinese goods and reciprocal tariffs on US exports have compressed margins for businesses on both sides of the tariff wall. A manufacturing business acquired at 8x EBITDA based on pre-tariff margins of 18% may now be generating margins of 13–14% — reducing the EBITDA base that supports the goodwill carrying amount and simultaneously increasing the WACC through higher policy uncertainty risk premiums.

Which Sectors Are Most Exposed in 2026

Not all goodwill impairment risk is equal. Based on the current macroeconomic and geopolitical environment, five sectors carry materially elevated impairment risk in 2026.

Sector 1: Manufacturing With China or Eastern European Supply Chain Exposure

Businesses acquired based on the economics of Chinese manufacturing (low-cost inputs, efficient Red Sea shipping, competitive export pricing) or Eastern European production (pre-war energy and labour costs) have seen both their cost structure and their competitive positioning disrupted.

The acquisition premium paid for these businesses — reflected in the goodwill carrying amount — was calculated on a supply chain economics that no longer exists. The WACC has increased. The projected cash flows have decreased. The impairment headroom has narrowed or disappeared.

For US advisory firms supporting M&A buy-side and sell-side valuations in manufacturing, this means that any goodwill impairment test relying on pre-war comparable multiples or pre-tariff margin projections needs an urgent update.

Sector 2: Logistics, Shipping, and Supply Chain Infrastructure

The Red Sea shipping crisis has had a direct and persistent impact on the value of logistics businesses. Container shipping companies, freight forwarding firms, and port infrastructure operators have seen their operating economics transformed — with some benefiting from higher shipping rates and some suffering from rerouting costs and customer attrition.

For the acquirers of logistics businesses in 2020–2022, the goodwill carrying amount reflects the value of pre-crisis operating models. The value-in-use DCF for those businesses, rebuilt with current WACC and current cash flow projections, may produce a recoverable amount significantly below the carrying amount.

Sector 3: European-Exposed Retail and Consumer Businesses

Businesses with significant European consumer exposure — particularly those with supply chains routed through Eastern Europe or with energy-intensive production — have faced the dual pressure of elevated input costs and subdued consumer demand in an inflation-squeezed European market.

UK and European FMCG, retail, and consumer discretionary businesses acquired in the 2019–2021 window at peak consumer confidence multiples carry goodwill that is now exposed to both higher WACCs and lower cash flow projections. The fair value measurement work required for these impairment tests requires current-market comparable multiples and explicit scenario analysis for the European consumer demand outlook.

Sector 4: Technology Businesses Acquired at 2021 Peak Multiples

The technology sector saw extraordinary valuation multiples in 2020–2021 — driven by pandemic-accelerated digital adoption, near-zero discount rates, and growth-stock exuberance. Many of those acquisitions generated substantial goodwill at acquisition. In 2026, with technology multiples substantially compressed and WACCs materially higher, the impairment risk embedded in 2021-vintage technology acquisitions is significant.

Specifically exposed: SaaS businesses acquired at 15–25x ARR multiples, B2B software businesses acquired at 10–15x revenue, and fintech businesses acquired at growth multiples that assumed continued low-rate conditions. For startup and VC valuation contexts and for PE-backed technology businesses approaching audit, this impairment risk must be proactively assessed.

Sector 5: Healthcare and Life Sciences With Pandemic-Era Acquisitions

The healthcare and life sciences sector saw a wave of pandemic-driven M&A in 2020–2022 — telehealth platforms, diagnostic businesses, PPE manufacturers, and vaccine-adjacent businesses — many of which were acquired based on pandemic-elevated cash flow projections that have since normalised. The goodwill arising from these acquisitions reflects peak-cycle values that are not supported by post-pandemic operating economics.

For PE funds holding healthcare businesses acquired in this window, the annual fund NAV valuation and LP reporting requirements demand an honest assessment of goodwill impairment risk in these assets — which our private equity and VC support team handles as standard.

Impairment Indicators — What Triggers an Interim Test

Under both ASC 350 and IAS 36 / AASB 136, management is required to perform an impairment test outside the annual cycle when indicators of impairment exist. In the current environment, multiple indicators are simultaneously present for a broad range of businesses.

Quantitative Indicators (Always Require Assessment)

Market capitalisation below net asset value — for listed companies, a sustained market cap below book value is a direct trigger
Significant decline in reported or projected cash flows — war-driven revenue loss, tariff-driven margin compression, or supply chain disruption affecting EBITDA
Significant increase in market interest rates — the 2022–2026 rate cycle qualifies directly
Reporting unit or CGU operating at a loss — any business unit in a loss position triggers automatic impairment assessment

Qualitative Indicators Specific to the Current Environment

Significant adverse change in business climate — US tariff announcements, Red Sea shipping disruption, and European energy cost increases all qualify
Loss of key customers or revenue streams — Russian market sanctions, Eastern European supply chain disruption, or Houthi-related shipping disruption affecting specific revenue lines
Regulatory or legal change adversely affecting the reporting unit — sanctions, trade restrictions, and export controls qualify
Significant reorganisation or restructuring — supply chain restructuring triggered by war or tariff policy

For any business that has experienced any of these indicators since its last annual impairment test, an interim test is not optional — it is required under applicable accounting standards. The question for management and auditors is not whether to test, but whether the test has been properly performed and documented.

Our audit and compliance liaison team supports the documentation and audit interface for interim impairment assessments.

The Correct Methodology — Value in Use vs Fair Value Less Costs of Disposal

Choosing the Right Basis

Under IAS 36 and AASB 136, the recoverable amount is the higher of value in use (VIU) and fair value less costs of disposal (FVLCD). Choosing incorrectly — or defaulting to VIU when FVLCD would produce a higher recoverable amount — can result in an unnecessary impairment charge or an impairment that could be avoided with proper methodology.

Value in Use is a discounted cash flow of the cash flows the entity expects to derive from the CGU in its current condition. It uses management’s own projections — typically 3–5 years of detailed forecasts plus a terminal value — discounted at a pre-tax WACC.

Fair Value Less Costs of Disposal is the price that would be received to sell the CGU in an orderly transaction between market participants at the measurement date, less estimated disposal costs. It uses market-based inputs — comparable transaction multiples, listed company multiples, or a market-participant DCF — rather than entity-specific assumptions.

In the current environment, FVLCD is often underused as a basis for recoverable amount because management teams default to the familiar VIU DCF methodology. But for businesses where market multiples — despite compression from 2021 peaks — still produce a higher recoverable amount than the management cash flow DCF, FVLCD can provide additional headroom that VIU would not capture.

Our goodwill and intangible impairment testing team assesses both VIU and FVLCD for every IAS 36 / AASB 136 engagement and selects the basis that properly reflects the higher recoverable amount.

The CGU Allocation Problem

One of the most common methodological errors in goodwill impairment testing — and one that auditors are increasingly scrutinising in the current environment — is incorrect CGU allocation.

Goodwill must be allocated to the lowest level at which it is monitored for internal management purposes — and that allocation must be reviewed whenever the business reorganises. War-driven supply chain restructuring, tariff-driven business model changes, and the exit from Russian or Eastern European markets have prompted significant business reorganisations at many companies acquired in the 2019–2022 window.

If a company has reorganised its business since the original goodwill allocation — changing management reporting structures, exiting markets, consolidating operations — the CGU allocation must be updated before the impairment test is performed. Performing a test on outdated CGU allocations is a methodology error that will be challenged in audit.

Sensitivity Analysis — The Auditor’s Minimum Expectation

In the current environment of genuine macroeconomic uncertainty, Big Four audit teams reviewing impairment tests under IAS 36 and ASC 350 consistently require a sensitivity analysis showing the impact of changes in key assumptions on the impairment outcome.

The minimum sensitivity disclosure that auditors expect in 2026 includes the discount rate sensitivity — the WACC increase required to eliminate remaining headroom — and the long-term growth rate sensitivity. For businesses near the impairment threshold, a sensitivity showing that a 0.5% WACC increase would trigger impairment is a materially different audit risk profile from one showing that a 3.0% WACC increase would be required.

ASIC in Australia, the SEC in the US, and the FRC in the UK have all specifically identified sensitivity disclosure quality in goodwill impairment testing as a financial reporting focus area. Under-documenting sensitivity is one of the fastest ways to generate an auditor qualification in the current environment.

What a Properly Documented 2026 Impairment Test Looks Like

A goodwill impairment test that will survive Big Four audit scrutiny in 2026 contains the following elements as a minimum:

1. CGU identification and allocation narrative — explicitly documenting how goodwill has been allocated to CGUs, when that allocation was last reviewed, and whether any business reorganisation has affected the allocation since the last test.

2. Impairment indicator assessment — a documented assessment of whether any quantitative or qualitative impairment indicators were present at the test date, with specific reference to the current macroeconomic and geopolitical environment.

3. WACC build — fully documented — risk-free rate (source, date, rate), equity risk premium (source, study, rate), beta (peer group, methodology, unlevering approach), size premium if applicable, country risk premium if applicable, all with explicit source citations. The WACC must be a pre-tax rate for IAS 36 VIU calculations.

4. Cash flow projections — management-approved — detailed projections for the explicit forecast period, with documented assumptions for revenue growth, EBITDA margins, capital expenditure, and working capital. Projections must be consistent with the most recent board-approved budget.

5. Terminal value methodology — terminal growth rate with documented justification, consistency check between the terminal growth rate and long-run GDP growth in relevant markets, and explicit confirmation that the terminal growth rate does not exceed the WACC.

6. Sensitivity analysis — at minimum, a two-way sensitivity showing the impact of WACC ± 1–2% and terminal growth rate ± 0.5–1.0% on the recoverable amount and the impairment headroom.

7. Conclusion and comparison — explicit comparison of recoverable amount to carrying amount, impairment charge calculation if applicable, and disclosure of remaining headroom if no impairment.

Our goodwill and intangible impairment testing service delivers all seven elements as standard — producing a report that is structured for immediate submission to audit review without supplementary documentation requests.

PE Funds — The Quarterly NAV Impairment Dimension

For PE funds, goodwill impairment in portfolio companies has a direct impact beyond statutory financial reporting — it affects fund NAV calculations and therefore LP reporting under IPEV guidelines.

IPEV guidelines require fair value measurement of PE portfolio investments at each reporting date. Where a portfolio company carries significant goodwill that is impaired at the statutory level — or where the fair value of the portfolio company has declined below its carrying amount — the fund’s NAV must reflect this reduction.

PE funds that have relied on cost or prior-round valuations for portfolio companies acquired in the 2019–2022 window are increasingly finding that a properly conducted 2026 IPEV fair value assessment produces values materially below the carrying amount — particularly for businesses in the sectors identified in Section 2.

For funds approaching an LP reporting cycle, the interaction between portfolio company goodwill impairment and IPEV fair value measurement requires careful coordination. Our due diligence and valuation and fund waterfall and ILPA reporting teams work together on exactly this coordination — ensuring that portfolio company-level impairment assessments and fund-level NAV calculations are consistent and properly documented.

The Cost of Getting This Wrong

Goodwill impairment failures — tests that should have identified an impairment charge but did not — carry specific consequences that make the risk of inadequate testing materially worse than the risk of recognised impairment.

SEC and ASIC enforcement: Both the SEC and ASIC have enforcement history on goodwill impairment — including restatements, comment letters, and in some cases regulatory sanctions — for companies that failed to recognise impairment in a timely manner. The SEC’s current comment letter program specifically targets goodwill impairment documentation in affected sectors.

Auditor qualification risk: A Big Four auditor who identifies that an impairment test was performed using 2021 WACC assumptions in a 2026 audit context has both the basis and the obligation to challenge the conclusion. An unresolved auditor challenge on goodwill impairment can delay financial statement signing — with knock-on effects on debt covenant compliance, banking relationships, and M&A transaction timelines.

Acquisition warranty exposure: For recently acquired businesses, a goodwill impairment that was foreseeable at the acquisition date but not identified in the vendor’s financial statements may trigger warranty and indemnity claims. Our litigation and forensic valuation team supports expert valuation work in W&I dispute contexts — which are increasing in frequency as 2021-vintage acquisitions encounter 2026 operating realities.

Debt covenant implications: Many acquisition finance structures include covenant tests based on net asset value or goodwill carrying amounts. An impairment charge that reduces net assets below a covenant threshold can trigger a technical default — regardless of the underlying cash generation of the business. Early identification of impairment risk allows management to engage lenders proactively rather than reactively.

Frequently Asked Questions

Our last goodwill impairment test was 18 months ago and showed comfortable headroom. Do we need to test again now?

Yes — if any of the impairment indicators described in Section 3 have been present since the last test. Specifically: the 2022–2026 interest rate increase qualifies as a significant increase in market interest rates, which is an explicit impairment indicator under both ASC 350 and IAS 36. A test showing comfortable headroom 18 months ago using a WACC that is now 2–3 percentage points too low is not reliable evidence that no impairment exists today. Our goodwill and intangible impairment testing team can perform a rapid preliminary assessment to determine whether a full test is required. Contact us for a scoping call.

We are a US company using ASC 350 — how is the test different from IAS 36?

The main practical differences are: ASC 350 tests at the reporting unit level (which may be larger than an IAS 36 CGU), ASC 350 allows a qualitative assessment (Step 0) to bypass quantitative testing if management can conclude it is more likely than not that fair value exceeds carrying amount, and ASC 350 impairment is measured as the excess of carrying amount over fair value (not the two-step test that was retired in 2017). In the current environment, the qualitative Step 0 assessment for any reporting unit with war-related cash flow disruption, tariff margin compression, or significant WACC increase is difficult to pass — meaning most affected businesses will need the full quantitative test.

What is the difference between goodwill impairment and intangible asset impairment?

Goodwill impairment is tested at the reporting unit / CGU level and cannot be reversed once recognised. Separately identified intangible assets acquired in a business combination — customer relationships, technology, trade names, non-compete agreements — are also subject to impairment testing under ASC 360 / IAS 36 when indicators exist. Our goodwill and intangible impairment testing service covers both goodwill and separately identified intangible assets in the same engagement.

Our auditors have already flagged goodwill as a key audit matter — what does that mean practically?

A goodwill impairment key audit matter (KAM) designation means your auditors have identified the test as one of the areas requiring the most significant auditor judgement in the engagement. Practically, this means: more detailed audit procedures on your WACC build and cash flow projections, specific testing of the sensitivity analysis, and potential involvement of the auditor’s own valuation specialists in reviewing your methodology. A KAM designation raises the documentation standard — a report that might pass a routine audit review will face more intensive scrutiny under KAM procedures. Our audit and compliance liaison service specifically supports the higher documentation standard that KAM designation requires.

We have a major acquisition closing in Q3 2026 — does the impairment issue affect the deal?

Yes — in two ways. First, the target’s balance sheet may carry goodwill from prior acquisitions that will be tested as part of your acquisition due diligence. A target with impairment risk on its balance sheet has a different quality of net assets than the headline numbers suggest. Second, your own PPA following the acquisition will generate new goodwill that immediately enters the impairment testing cycle — and in the current WACC environment, the headroom in your year-one impairment test may be narrower than expected. Our PPA service and due diligence and valuation capabilities cover both the target-side impairment assessment and the post-close PPA work.

How much does a goodwill impairment test cost with Synpact?

A standard goodwill impairment test under IAS 36 or ASC 350 for a mid-market business with 2–4 CGUs is priced in the $3,500–$6,000 range at Synpact — compared to $20,000–$45,000 at a US boutique valuation firm and $40,000–$100,000 at Big Four. See our transparent pricing guide for the full engagement fee breakdown. Fixed fee, revisions included, 7–10 business day standard turnaround.

For Australian companies under AASB 136 — is there anything specific to note in 2026?

ASIC has specifically flagged goodwill impairment as a focus area in its financial reporting surveillance program for 2025–2026 — including scrutiny of discount rates, CGU allocation, and sensitivity disclosure. Australian companies applying AASB 136 face the same WACC increase dynamics as US and UK companies, with the additional dimension of ASIC scrutiny. Our Australian advisory firm guide covers the AASB 136-specific requirements, and our impairment testing service is structured to meet ASIC’s current documentation expectations.

Conclusion: Proactive Is Always Better Than Reactive

The goodwill impairment wave in 2026 is not a risk that management teams can defer until the auditor raises it. By the time an auditor challenges an impairment test in the annual audit cycle, the timeline for remediation is compressed, the documentation pressure is maximum, and the options for avoiding a restatement are limited.

The businesses managing this well are the ones that have already commissioned updated impairment assessments — using current WACC inputs, current cash flow projections, and current audit-standard documentation — before the annual audit cycle begins.

The cost of a properly documented impairment test is a fraction of the cost of a restatement, a covenant breach, or an auditor qualification. And with Synpact’s fixed-fee, 7–10 business day turnaround, it is also a fraction of the cost and time that the same work requires from a Big Four or domestic boutique provider.

→ Commission Your 2026 Impairment Test — Fixed Fee, Audit-Ready in 10 Days

Related Reading on Synpact Blog: